This phase III trial compares the effect of adding levocarnitine to standard chemotherapy vs. standard chemotherapy alone in protecting the liver in patients with leukemia or lymphoma. Asparaginase is part of the standard of care chemotherapy for…
- Investigator
- Brian Stover
- Status
- Accepting Candidates
- Ages
- 15 Years - 40 Years
- Sexes
- All